1. Home
  2. Assessing and Prioritizing Clinical Trial Sites for Phase 3 Lassa Fever Vaccine Trials in West Africa: A Regional Site Assessment Initiative

Assessing and Prioritizing Clinical Trial Sites for Phase 3 Lassa Fever Vaccine Trials in West Africa: A Regional Site Assessment Initiative

West African Health Organization
01 BP 153 Bobo-Dioulasso 01 / Burkina Faso
(226) 20 97 01 00 / (226) 20 97 57 75
(226) 20 97 57 72
wahooas@wahooas.org